EUCTR2012-001975-36-IT进行中（未招募）不适用
Evaluation on the efficacy of docosahexaenoic acid for the treatment of nonalcoholic fatty liver disease in children - DHA for fatty liver in children
AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA0 个研究点开始时间: 2012年6月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Obese children and adolescents (BMI > 95th percentile), aged 6 to 18 years, with NAFLD
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 80
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •viral and autoimmune hepatitis, Wilson disease, and genetic and metabolic liver diseases
研究者
相似试验
尚未招募
2 期
Study of Omega-3 Fatty Acid Supplementation With Inhaled Cortiocosteroids in Asthma patients.CTRI/2019/09/021105Council of Scientific and Industrial Research
已完成
不适用
Efficacy and safety of docosahexaenoic acid + eicosapentaenoic acid therapy in patients with successful coronary intervention (ESSENCE Study)HypertriglyceridaemiaJPRN-UMIN000018056Department of Cardiology, Fukuoka University Hospital40
已完成
不适用
The effect of docosahexaenoic acid and eicosapentaenoic acid -enriched milk beverage ingestion on erythrocyte plasma membrane fatty acid levels of the elderlyThe elderlyJPRN-UMIN000031699Shimane University108
招募中
3 期
Effect of Docosahexaenoic Acid Supplementation on neonatal outcomes of pereterm infantsutrition of premature babies / Growth of premature babies / Prognosis of premature babies.IRCT20221120056556N2Shahid Beheshti University of Medical Sciences384
已完成
1 期
Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm NeonatesNecrotizing EnterocolitisNCT01745510Coordinación de Investigación en Salud, Mexico225